China Chemical & Pharmaceutical Group Overvie · Sedative, hypnotics & tranquilizers Electrolytes &...
Transcript of China Chemical & Pharmaceutical Group Overvie · Sedative, hypnotics & tranquilizers Electrolytes &...
China Chemical & Pharmaceutical GroupOverview
Page 2
Agenda
CCPG Vision and Core Value
Company Presentations
Global Business Development
1
2
3
4
CCPG Family
Page 3
Agenda
CCPG Vision and Core Value
Company Presentations
Global Business Development
1
2
3
4
CCPG Family
Page 4
CCPC Vision and Core Value
Vision
To be the Most Trusted Healthcare Enterprise in the Greater China Area
Core Value
Enthusiasm, Innovation, Care, Health
Page 5
Agenda
CCPG Vision and Core Value
Company Presentations
Global Business Development
1
2
3
4
CCPG Family
Page 6
CCPG Organization Chart
Chunghwa Yuming Healthcare Co., Ltd. (CYH), Taiwan. Medical product and food supplement marketing & sales
Chunghwa Biomedical Technology Co. Ltd. (CBT), Taiwan. Non-medical product marketing & sales and senior home care services.
Suzhou Chunghwa Chemical & Pharmaceutical Industrial Co., Ltd.(SCCPC), China. Generic drug R&D, manufacturing, marketing and sales
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB), Taiwan, USA. Chemical & biological API R&D, production, marketing and sales
China Chemical & Pharmaceutical Co. (CCPC), Taiwan. The mother company. Generic drug R&D, and manufacturing
Page 7
Agenda
CCPG Vision and Core Value
Company Presentations
Global Business Development
1
2
3
4
CCPG Family
Page 8
China Chemical & Pharmaceutical Co., Ltd. (CCPC)
Profile
Founded in 1952 The first public listed pharmaceutical Co. in
Taiwan Stock Exchange. The first generic pharmaceutical company
in Taiwan to meet GMP(1984) & cGMP(2001) guidelines The first Taiwan pharmaceutical company
invested in China (1993) One of the largest contract manufacturers
for human pharmaceutical & animal health products in Taiwan
Page 9
CCPC Headquarters and Manufacturing Plants
Taipei
Hsinfong
Taichung
Tainan
Headquarters
Hsinfong Plant IHuman Products
Tainan plant I Animal Health products
Tainan Plant IIHuman Pharmaceuticals Taichung Plant
Penicillin Products
Tainan plant IIICephalosporin Products
Research andDevelopment Center
Hsinfong Plant IIImmunosuppressant
Products
Page 10
CCPC Product Forms
Product lines include
Tablets
Capsules
Injection
Solutions
Ointments
Veterinary products
Premixes, additives
Page 11
CCPC Major Products
Anti-infective drugs
Cardiovascular agents
Hypolipedemics
Remedies for peptic ulcer
Anti-pyretics & analgesics
Anti-diabetic agents
Anti-tussives & expectorants
Anti-histamines
Remedies for asthma
Anti-fungal and anti-viral agents
Sedative, hypnotics & tranquilizers
Electrolytes & hemodialysis preparations
Vitamin preparations
Animal health products
Page 12
CCPC Business Development Strategy
Maximize short and long term revenues
Further strengthen pipelines A fully vertically integrated pharmaceutical company
Development of niche generics into global markets
Application of CCPC unique controlled-release technology of drug delivery system for niche product development
Reinforce Organizational capabilities Product portfolio optimization
Global contract manufacturing business
How can CCPC drive growth, whilst building and defending it’s existing product portfolio?
Page 13
Pharmaceutical Research Institute
Pharmaceutical Research Institute
Formulation Research Laboratory
Special Project Laboratory
Analytical Research Laboratory Production
Technology Development
Laboratory
1. Osmotic Pump Device2. Matrix Device3. Repeated-Release Device4. Delayed-Release Device5. Modified-Release Device6. Multiple-Layer Device7. Orally Disintegrating Tablet Device
Technological Platform 1. 2.
3. 4. 5.
6. 7.
CCPC Drug Delivery System Platform
Osmotic Pump (Tablet)
Matrix (Tablet)
Repeated-Release (Tablet)
Delayed-Release (Pellet)
Modified-Release (Pellet)
Multiple-Layer (Tablet)
Orally Disintegrating Tablet
Page 14
CCPC Niche Product DevelopmentApplication of CCPC unique controlled-release technology of drug delivery system for niche product development
Delayed-ReleaseDevice
CCPC Drug
Delivery System Platform
Nifecardia*(Nifedipine)
Xadosin*(Doxazosin)
Zotan*(Tamulosin)
Rafax*(Venlafaxine)
Setizin-CP 12(Cetirizine/Pseudoephedrine)
Vantydin 12*(Fexofenadine/Pseudoephedrine)
Finska LP 24(Loratadine/Pseudoephedrine)
Taquidine*(Lansoprazole)
Finska LP 12*(Loratadine/Pseudoephedrine)
Naposin(Naproxen)
Trenfylline*(Pentoxifylline)
Glicron*(Gliclazide)
Glibudon*(Metformin)
Arizole*(Aripiprazole)
Zotan*(Tamulosin)
Olan*(Olanzapine)
Page 15 * BE indicated Global MKT Contract
Page 16
CCPC Collaborators
Exclusive Agent
Distributor
Contract manufacturer
R&D collaborator
Page 17
Chunghwa Yuming Healthcare Co., Ltd. (CYH)
Profile
CYH is100% owned by CCPC Marketing and sales of human
pharmaceutical products and functional foods Agency for multinational
pharmaceutical Actively looking for export/import
and license-in/out business opportunities
Page 18
CYH Business Strategy
Prescription products CCPC products
License-in products
OTC products CCPC products
License-in products
Medical Equipments Omron
Functional Foods Homart
Keep Revenues and Profit Growing
Page 19
Chunghwa Biomedical Technology Co., Ltd. (CBT)
Profile
CBT is100% owned by CCPC Founded in March, 2006 CBT is 100% owned by CCPC Marketing and sales of consumer,
skin care products and health foods Providing non-medical senior
homecare services
Page 20
Suzhou Chung-Hwa Chemical & Pharmaceutical Industrial Co., Ltd. (SCCPC)
Profile
CYH is100% owned by CCPC Established in April,1993 Total investment: US $60 Million Location: Suzhou Hi-Tech,
Industrial District, Suzhou, China GMP Plant : 45,000 square meters
Page 21
SCCPC Capabilities
Qualification GMP in 2014
Annual production capacity Powder Injection: 60,000,000 vials Tablet: 1,800,000,000 tablets Capsule: 1,800,000,000 capsules Granule:400,000,000 sachets Disinfection Solution for Contact Lenses:
10,000,000 bottles Mouth Wash Solution: 8,000,000 bottles
R&D 8-10 new products annually
Contract research and manufacturing
Marketing, distribution and promotion
Page 22
SCCPC is a Generic Pharmaceutical Co.
Product Category
Antibiotics (Cefalosporins mainly)
Hypolipidemics
Gastrointestinal drug
Gynaecological drug
Antipyretics
Hypoglycomics
Antidepressant
Disinfection solution for contact lenses
Antiseptic solution
Page 23
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB)
Profile Founded in 1964 First registered and one of the largest bulk
pharmaceutical chemical manufacturers in Taiwan First Taiwan FDA approved plant (1984)
Turning Points in 1997 Formed the New Management Team in 1997 Invested US$ 20 million to construct 4 cGMP Plants for Synthetic Products 2 cGMP Plants for Biotechnology Products
Established US Sales Office-Pharmaports in 2000 Products Developing both synthetic & biotech products Participate new drug development and contract
manufacturing Global Market Oriented with Emphasis on U.S.A., Europe, Japan
Initial public offering on December 20, 2010 Obtain the necessary land for plant expansion in 2012
Page 24
CCSB cGMP InspectionsYear Authorities Products
2005 USFDA Pravastatin
2006 TFDA Prindopril Erbumine
2007 KFDA Methocarbamol
2008 NIPTFDA
TrandolaprilRapamycin
2009 German AuthorityTFDA
PravastatinMethocarbamol, Pravastatin
2010 TFDA Tacrolimus, Mycophenolate Mofetil
2011 USFDA Mycophenolate Mofetil, Tacolimus/SD20, Dexbrompheniramine Maleate
2012 German AuthorityTFDA
PravastatinFluconazole, Mataxalone, Rapamycin
2013 PMDA Tacrolimus
Page 25
R&D Product Pipeline
Rapamycin Products under Investigation
Everolimus Rosuvastatin: Antihyperlipidemics
Caspofungin Entecavir: Antiviral Drug
Micafungin Carfilzomib: Anti-Cancer Drug
Ethyl Icosapentate Ingenol Mebutate: Anti-Cancer Drug
CCSB is a Niche Pharmaceutical API Company
DMF List
DMF 8625 Dexbrompheniramine Maleate
DMF 13080 Methocarbamol
DMF 14234 Guaifenesin
DMF 14235 Pravastatin Sodium
DMF 17399 Rapamycin
DMF 17573 Trandolapril
DMF 18494 Mycophenolate Mofetil
DMF 18985 Tacrolimus
DMF 22430 Olopatadine HCl
DMF 23213 Tacrolimus SD20
DMF 23434 Metaxalone
DMF 23435 Mycophenolate Sodium
DMF 24372 Mycophenolate Mofetil HCl
DMF 26271 Ethyl Icosapentate
DMF 26819 Everolimus Pre-Mix
DMF 27216 Everolimus
Page 26
CCSB Product Categories
Page 27
Why CCSB?
Over 45 years of bulk API manufacturing experience
US, Europe and Japan Health Authorities approved cGMP facilities for synthesis & biotech APIs
Fully cGMP trained and experienced personnel
Strong R&D support
Proven records for cost effective and on-time delivery of contract manufacturing from lab to commercial scales
Good communication skills & prompt response
Pilot Plant Reactor Feeding Tank Fermentor
Page 28
Agenda
CCPG Vision and Core Value
Company Presentations
Global Business Development
1
2
3
4
CCPG Family
Page 29
Vertical Integration (API & Finished Dosage Form)CCPC is an Integrated Pharmaceutical CompanyNiche and Innovative Product Development
API Formulation Production Marketing & Sales